Numerai’s Calumet Specialty Products CLMT Stock Holding History

Numerai’s Portfolio CLMT Stock Details CLMT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-31,188	Closed	-$620K	–	776
2025 Q4	$620K	Buy	+31,188	New	+$600K	0.07%	359

Other funds holding CLMT

TSC

Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

WDOM

Wasserstein Debt Opportunities Management New York $189M AUM 169.75% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

AAA

Adams Asset Advisors Dallas, Texas $882M AUM 42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Numerai's CLMT Position: Q1 2026 in Review

Numerai sold out of Calumet Specialty Products (CLMT) in Q1 2026, closing a stake of 31,188 shares — an estimated $620K sold.

Numerai first reported a position in CLMT in Q4 2025 and held it in 1 quarter. The position peaked at $620K in Q4 2025. 180 funds tracked by Wall St. Rank hold CLMT as of Q1 2026.

Numerai reported no remaining Calumet Specialty Products position as of Q1 2026 after selling out during the quarter.
Numerai sold 31,188 Calumet Specialty Products shares in Q1 2026, an estimated $620K.
Numerai first reported a position in Calumet Specialty Products in Q4 2025 and held it in 1 quarter.
Numerai's Calumet Specialty Products position peaked at $620K in Q4 2025.
180 funds tracked by Wall St. Rank held Calumet Specialty Products as of Q1 2026.

Based on Numerai's 13F filing for Q1 2026, filed 15 May 2026.